BUZZ-Concord Healthcare rises after China approves therapy services licence

Reuters09-16

** Shares of Hong Kong-listed Concord Healthcare Group

rise as much as 5.7% to HK$18.56, their biggest intraday pct gain since Aug 1

** Stock of the oncology healthcare service provider on track to snap six consecutive sessions of decline, and is fifth pct gainer in healthcare index , which is down 1.2%

** Concord Healthcare said China's National Health Commission had on Sept 13 granted approval to the company's application for licence to deploy large-scale medical equipment for its planned proton therapy services

** Hang Seng Commerce & Industry Index slips 0.5% and Hang Seng Index eases 0.4%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467506528?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-16 10:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467506528","market":"hk","top_or_hot":-1,"title":"BUZZ-Concord Healthcare rises after China approves therapy services licence","media":"Reuters","content":"<html><body><p>** Shares of Hong Kong-listed Concord Healthcare Group</p><p>  rise as much as 5.7% to HK$18.56, their biggest intraday pct gain since Aug 1</p><p>   ** Stock of the oncology healthcare service provider on track to snap six consecutive sessions of decline, and is fifth pct gainer in healthcare index   , which is down 1.2%</p><p>   ** Concord Healthcare said China's National Health Commission had on Sept 13 granted approval to the company's application for licence to deploy large-scale medical equipment for its planned proton therapy services </p><p>   ** Hang Seng Commerce &amp; Industry Index    slips 0.5% and Hang Seng Index    eases 0.4%</p><p>(Reporting by Donny Kwok)</p><p>((donny.kwok@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Concord Healthcare rises after China approves therapy services licence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Concord Healthcare rises after China approves therapy services licence\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-16 10:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of Hong Kong-listed Concord Healthcare Group  rise as much as 5.7% to HK$18.56, their biggest intraday pct gain since Aug 1   ** Stock of the oncology healthcare service provider on track to...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02453","symbol_name":"美中嘉和","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2467506528","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467506528","pubTimestamp":1726452793,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of Hong Kong-listed Concord Healthcare Group  rise as much as 5.7% to HK$18.56, their biggest intraday pct gain since Aug 1   ** Stock of the oncology healthcare service provider on track to snap six consecutive sessions of decline, and is fifth pct gainer in healthcare index   , which is down 1.2%   ** Concord Healthcare said China's National Health Commission had on Sept 13 granted approval to the company's application for licence to deploy large-scale medical equipment for its planned proton therapy services    ** Hang Seng Commerce & Industry Index    slips 0.5% and Hang Seng Index    eases 0.4%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02453":"美中嘉和","BK1209":"保健护理机构"},"translate_title":"BUZZ-Concord Healthcare在中国批准治疗服务许可证后股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02453":0.9},"content_text":"** Shares of Hong Kong-listed Concord Healthcare Group  rise as much as 5.7% to HK$18.56, their biggest intraday pct gain since Aug 1   ** Stock of the oncology healthcare service provider on track to snap six consecutive sessions of decline, and is fifth pct gainer in healthcare index   , which is down 1.2%   ** Concord Healthcare said China's National Health Commission had on Sept 13 granted approval to the company's application for licence to deploy large-scale medical equipment for its planned proton therapy services    ** Hang Seng Commerce & Industry Index    slips 0.5% and Hang Seng Index    eases 0.4%(Reporting by Donny Kwok)((donny.kwok@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467506528"}